Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization

International Journal of Cardiology

Volumn 129, Issue 2, 2008, Pages 288-291

  Frøbert, Ole ^a,b   Hjortshøj, Søren P ^a   Simonsen, Ulf ^b   Ravkilde, Jan ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Coronary artery; Endothelium; Ischemic heart disease; Myocardial markers

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ARGININE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARGININE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERY DISEASE; ENDOTHELIUM; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES;

EID: 50349098222     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.152     Document Type: Article

References (21)

1. Cooke J.P. Asymmetrical dimethylarginine: the Uber marker?. Circulation 109 (2004) 1813-1818
2. Vallance P., and Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24 (2004) 1023-1030
3. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
4. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
5. Krempl T.K., Maas R., Sydow K., Meinertz T., Boger R.H., and Kahler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. Eur Heart J 26 (2005) 1846-1851
6. Lu T.M., Ding Y.A., Lin S.J., Lee W.S., and Tai H.C. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24 (2003) 1912-1919
7. Tousoulis D., Davies G.J., Tentolouris C., Goumas G., Stefanadis C., and Toutouzas P. Vasomotor effects of d- and l-arginine in stenotic atheromatous coronary plaque. Heart 86 (2001) 296-301
8. Boger R.H., Bode-Boger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
9. Martinez A.C., Stankevicius E., Jakobsen P., and Simonsen U. Blunted non-nitric oxide vasodilatory neurotransmission in penile arteries from renal hypertensive rats. Vascul Pharmacol 44 (2006) 354-362
10. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 336 Pt 1 (1998) 1-17
11. Dhanakoti S.N., Brosnan J.T., Herzberg G.R., and Brosnan M.E. Renal arginine synthesis: studies in vitro and in vivo. Am J Physiol 259 (1990) E437-E442
12. Dierkes J., Westphal S., Martens-Lobenhoffer J., Luley C., and Bode-Boger S.M. Fenofibrate increases the l-arginine:ADMA ratio by increase of l-arginine concentration but has no effect on ADMA concentration. Atherosclerosis 173 (2004) 239-244
13. Bernard A.C., Fitzpatrick E.A., Maley M.E., et al. Beta adrenoceptor regulation of macrophage arginase activity. Surgery 127 (2000) 412-418
14. Ikeda K., Nara Y., Tagami M., and Yamori Y. Nitric oxide deficiency induces myocardial infarction in hypercholesterolaemic stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 24 (1997) 344-348
15. Prados P., Matsunaga H., Mori T., et al. Changes of plasma l-arginine levels in spontaneously hypertensive rats under induced hypotension. Biomed Chromatogr 13 (1999) 27-32
16. Boger R.H., Sydow K., Borlak J., et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87 (2000) 99-105
17. Pereira E.C., Bertolami M.C., Faludi A.A., Salem M., Bersch D., and Abdalla D.S. Effects of simvastatin and l-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects. Free Radic Res 37 (2003) 529-536
18. Eid H.M., Eritsland J., Larsen J., Arnesen H., and Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 166 (2003) 279-284
19. Boger R.H., Bode-Boger S.M., Tsao P.S., Lin P.S., Chan J.R., and Cooke J.P. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36 (2000) 2287-2295
20. Iuliano L., Pratico D., Greco C., et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 37 (2001) 76-80
21. Leiper J.M., and Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 62 Suppl 13 (2006) 33-38